DEPARTMENTS: Drugs in DermatologyHydroquinoneChow, Maggie L.; Jacob, Sharon E.Author Information Maggie L. Chow, PhD, Department of Internal Medicine, Kaiser Los Angeles Medical Center, CA. Sharon E. Jacob, MD, Loma Linda University, Loma Linda, CA. Conflicts of interest: Sharon E. Jacob served as an independent investigator on the safety and efficacy of T.R.U.E. Test (Smart Practice; Phoenix, AZ) Panels 1.1, 2.1, and 3.1 in children and adolescents, Pediatric Research Equity Act (PREA-1) trial, and now serves as an investigator on PREA-2. She has served as a consultant for Johnson & Johnson. She has no conflicts of interest associated with the subject matter in this manuscript. Maggie Chow has no relevant disclosures or conflicts of interest. Correspondence concerning this article should be addressed to Sharon E. Jacob, MD, Department of Dermatology, Loma Linda University, 11370 Anderson Street, Suite 2600, Loma Linda, CA 92354. E-mail: [email protected] Journal of the Dermatology Nurses’ Association: January/February 2016 - Volume 8 - Issue 1 - p 78-79 doi: 10.1097/JDN.0000000000000196 Buy Metrics Abstract The purpose of this section is to focus on common medications used in the field of dermatology: how they work, how they are utilized, side effects, and available routine alternatives. In this article, we discuss the mechanism of action, usage, adverse effects, and alternatives of the commonly used topical medication hydroquinone. Copyright © 2016 by the Dermatology Nurses' Association.